drugset / Trial / NCT03745417
Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis
Phase 1/2
Unknown
5 enrolled
Guangdong Provincial Hospital of Traditional Chinese Medicine
Peking Union Medical College Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Expanded Umbilical Cord Mesenchymal Stem Cells on patients with moderate to severe psoriasis. Any adverse events related to UCMSCs infusion will be monitored.The primary outcome is the improvement rate of PASI(Psoriasis Area and Severity Index) and treatment response will be computed from PASI before and after UCMSCs infusion.
Timeline
- Start
- 2021-08-31
- Primary completion
- 2022-08-28
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 2e+06 cells/kg | Intravenous |